- Home
- XPEV vs SRPT Comparison
XPEV vs SRPT Comparison
Compare XPEV & SRPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XPEV
- SRPT
- Stock Information
- Founded
- XPEV 2015
- SRPT 1980
- Country
- XPEV China
- SRPT United States
- Employees
- XPEV N/A
- SRPT N/A
- Industry
- XPEV Auto Manufacturing
- SRPT Biotechnology: Pharmaceutical Preparations
- Sector
- XPEV Consumer Discretionary
- SRPT Health Care
- Exchange
- XPEV Nasdaq
- SRPT Nasdaq
- Market Cap
- XPEV 12.0B
- SRPT 9.8B
- IPO Year
- XPEV 2020
- SRPT 1997
- Fundamental
- Price
- XPEV $18.22
- SRPT $53.79
- Analyst Decision
- XPEV Buy
- SRPT Buy
- Analyst Count
- XPEV 8
- SRPT 22
- Target Price
- XPEV $21.71
- SRPT $156.77
- AVG Volume (30 Days)
- XPEV 12.6M
- SRPT 2.8M
- Earning Date
- XPEV 05-20-2025
- SRPT 04-30-2025
- Dividend Yield
- XPEV N/A
- SRPT N/A
- EPS Growth
- XPEV N/A
- SRPT N/A
- EPS
- XPEV N/A
- SRPT 2.34
- Revenue
- XPEV $5,598,814,778.00
- SRPT $1,901,979,000.00
- Revenue This Year
- XPEV $99.50
- SRPT $66.51
- Revenue Next Year
- XPEV $35.42
- SRPT $21.66
- P/E Ratio
- XPEV N/A
- SRPT $23.00
- Revenue Growth
- XPEV 33.22
- SRPT 52.97
- 52 Week Low
- XPEV $6.55
- SRPT $48.01
- 52 Week High
- XPEV $27.16
- SRPT $173.25
- Technical
- Relative Strength Index (RSI)
- XPEV 43.46
- SRPT 31.45
- Support Level
- XPEV $16.13
- SRPT $53.02
- Resistance Level
- XPEV $21.25
- SRPT $56.34
- Average True Range (ATR)
- XPEV 1.11
- SRPT 4.23
- MACD
- XPEV -0.14
- SRPT 1.05
- Stochastic Oscillator
- XPEV 37.66
- SRPT 29.70
About XPEV XPeng Inc.
Founded in 2015, XPeng is a leading Chinese smart electric vehicle company that designs, develops, manufactures, and markets EVs in China. Its products primarily target the growing base of technology-savvy middle-class consumers in the midrange to high-end segment in China's passenger vehicle market. The company sold over 141,000 EVs in 2023, accounting for about 2% of China's passenger new energy vehicle market. It is also a leader in autonomous driving technology.
About SRPT Sarepta Therapeutics Inc. (DE)
Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Majority of company's product candidates are at an early stage of development.